Consolidated revenue grew 8.83% and net profit rose 14.54% year-over-year, while standalone profit and EPS declined due to strategic product transfers to a subsidiary. Export revenue increased 5.59%, and a 120% cash dividend was recommended. The company remains debt-free and continues to invest in capacity and innovation.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.